Hirst D G, Brown J M, Hazlehurst J L
Cancer Res. 1983 May;43(5):1961-5.
The ability of three nitroimidazoles [SR-2508, misonidazole (MISO), and benznidazole] with differing octanol-water partition coefficients to enhance the cytotoxicity of the nitrosourea 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) was evaluated in two mouse tumors (the KHT sarcoma and the SCC VII/St carcinoma). These results were compared with the effect on two normal tissues (bone marrow CFU-S and testis spermatogonia). When given as a large single dose, benznidazole was more effective than MISO in enhancing the cytotoxicity of CCNU to both tumors. SR-2508 had no effect. The advantage of benznidazole over MISO was lost, however, because benznidazole gave more toxicity in the normal tissues than MISO. In experiments where the nitroimidazoles were administered by multiple small injections to maintain a blood plasma level between 50 and 100 micrograms/ml, benznidazole was also more effective than MISO in enhancing CCNU cytotoxicity in the tumors. In each case, enhancement was rather less than that obtained with large single injections. Again, however, benznidazole did not produce a consistently greater therapeutic gain than MISO because it also enhanced normal tissue toxicity while MISO did not. SR-2508 was ineffective in both tumors and normal tissues. We conclude that neither SR-2508 nor benznidazole are superior to MISO in combination with CCNU.
在两种小鼠肿瘤(KHT肉瘤和SCC VII/St癌)中,评估了三种具有不同辛醇-水分配系数的硝基咪唑类药物[SR-2508、米索硝唑(MISO)和苄硝唑]增强亚硝基脲1-(2-氯乙基)-3-环己基-1-亚硝基脲(CCNU)细胞毒性的能力。将这些结果与对两种正常组织(骨髓CFU-S和睾丸精原细胞)的影响进行了比较。当大剂量单次给药时,苄硝唑在增强CCNU对两种肿瘤的细胞毒性方面比MISO更有效。SR-2508没有效果。然而,苄硝唑相对于MISO的优势丧失了,因为苄硝唑在正常组织中产生的毒性比MISO更大。在通过多次小剂量注射给予硝基咪唑类药物以维持血浆水平在50至100微克/毫升之间的实验中,苄硝唑在增强CCNU对肿瘤的细胞毒性方面也比MISO更有效。在每种情况下,增强作用都比大剂量单次注射时要小。然而,同样地,苄硝唑并没有比MISO产生持续更大的治疗增益,因为它也增强了正常组织毒性,而MISO没有。SR-2508在肿瘤和正常组织中均无效。我们得出结论,在与CCNU联合使用时,SR-2508和苄硝唑都不比MISO更优越。